Physician profile
Kristen Gorbitz
NPI 1356392989
$1,145.63
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $465 · 2022: $359 · 2023: $127 · 2024: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $321.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $166.77 | 2021 | |
| Pfizer INC. | $150.66 | 2021-2023 | |
| Abbott Laboratories | $133.10 | 2024 | Proclaim |
| Sumitomo Pharma America, INC. | $100.13 | 2023-2024 | Myfembree |
| Myovant Sciences INC. | $95.69 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $91.01 | 2021-2023 | |
| Abbvie INC. | $85.93 | 2022 | |
| Amgen INC. | $62.08 | 2022 | |
| Avion Pharmaceuticals | $56.51 | 2021-2022 | |
| Therapeuticsmd, INC. | $43.43 | 2021 | |
| Exeltis, USA INC. | $40.62 | 2021-2022 | |
| Coopersurgical, INC. | $37.85 | 2021-2022 | |
| Aspira Women'S Health INC | $30.01 | 2022-2024 | Ova1 |
| Organon LLC | $27.26 | 2024 | |
| Merck Sharp & Dohme LLC | $13.37 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $11.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristen Gorbitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.